Frankfurt - Delayed Quote EUR

Janus Henderson Capital Funds plc - Global Life Sciences Fund Class H2 HEUR (0P0000ZTO4.F)

26.53 -0.08 (-0.30%)
At close: April 25 at 10:00 PM GMT+2

Top 10 Holdings (37.45% of Total Assets)

SymbolCompany% Assets
LLY
Eli Lilly and Company 6.66%
UNH
UnitedHealth Group Incorporated 5.99%
NOVO-B.CO
Novo Nordisk A/S 4.82%
MRK
Merck & Co., Inc. 3.57%
AZN.L
AstraZeneca PLC 3.57%
ABBV
AbbVie Inc. 3.22%
ABT
Abbott Laboratories 2.49%
SAN.PA
Sanofi 2.47%
VRTX
Vertex Pharmaceuticals Incorporated 2.38%
BSX
Boston Scientific Corporation 2.29%

Sector Weightings

Sector0P0000ZTO4.F
Healthcare   100.00%
Real Estate   0.00%
Technology   0.00%
Utilities   0.00%
Industrials   0.00%
Energy   0.00%

Overall Portfolio Composition (%)

Cash 0.63%
Stocks 97.87%
Bonds 0.01%
Others 1.49%
Preferred 0.00%
Convertible 0.00%

Bond Ratings

US Government 0.00%
AAA --
AA --
A --
BBB --
BB --
B --
Below B --
Other --

Equity Holdings

Average 0P0000ZTO4.F Category Average
Price/Earnings 0.03 --
Price/Book 0.2 --
Price/Sales 0.42 --
Price/Cashflow 0.05 --
Median Market Cap 52,428.02 --
3 Year Earnings Growth 1 --

Bond Holdings

Average 0P0000ZTO4.F Category Average
Maturity -- --
Duration 10 --
Credit Quality -- --

Performance & Risk

YTD Return 1.96%
5y Average Return 8.38%
Rank in Category (ytd) --
% Rank in Category (ytd) --
Beta (5Y Monthly) --
Morningstar Risk Rating --

Fund Overview

Category --
Fund Family Janus Henderson Investors
Net Assets --
YTD Return 8.03%
Yield 0.00%
Morningstar Rating --
Inception Date Jan 31, 2008

Fund Summary

Related Tickers